If the fixed rate ends up at 1.3% and the inflation-based variable rate ends up at 3.58% beginning Nov. 1, the resulting ...
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, ...